Anxiety Affects Cognition Differently in Healthy Apolipoprotein E ε4 Homozygotes and Non-CarriersSTONNINGTON, Cynthia M; LOCKE, Dona E. C; DUECK, Amylou C et al.The Journal of neuropsychiatry and clinical neurosciences. 2011, Vol 23, Num 3, pp 294-299, issn 0895-0172, 6 p.Article

Risk factors associated with local and in-transit recurrence of cutaneous melanomaSTUCKY, Chee-Chee H; GRAY, Richard J; DUECK, Amylou C et al.The American journal of surgery. 2010, Vol 200, Num 6, pp 770-774, issn 0002-9610, 5 p.Conference Paper

A significant number of women present with palpable breast cancer even with a normal mammogram within 1 yearHAAKINSON, Danielle J; STUCKY, Chee-Chee H; DUECK, Amylou C et al.The American journal of surgery. 2010, Vol 200, Num 6, pp 712-717, issn 0002-9610, 6 p.Conference Paper

Effect of Body Mass Index on Tumor Characteristics and Disease-Free Survival in Patients From the HER2-Positive Adjuvant Trastuzumab Trial N9831CROZIER, Jennifer A; MORENO-ASPITIA, Alvaro; BALLMAN, Karla V et al.Cancer. 2013, Vol 119, Num 13, pp 2447-2454, issn 0008-543X, 8 p.Article

Depressive Symptoms in Healthy Apolipoprotein E ε4 Carriers and Noncarriers: A Longitudinal StudyLOCKE, Dona E. C; DUECK, Amylou C; STONNINGTON, Cynthia M et al.The Journal of clinical psychiatry. 2013, Vol 74, Num 12, pp 1256-1261, issn 0160-6689, 6 p.Article

Impact of PTEN Protein Expression on Benefit From Adjuvant Trastuzumab in Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the North Central Cancer Treatment Group N9831 TrialPEREZ, Edith A; DUECK, Amylou C; KUTTEH, Leila A et al.Journal of clinical oncology. 2013, Vol 31, Num 17, pp 2115-2122, issn 0732-183X, 8 p.Article

Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 EffectCASELLI, Richard J; DUECK, Amylou C; LOCKE, Dona E. C et al.The New England journal of medicine. 2009, Vol 361, Num 3, issn 0028-4793, 255-263 [9 p.]Article

Soluble Human Epidermal Growth Factor Receptor 2 (HER2) Levels in Patients With HER2-Positive Breast Cancer Receiving Chemotherapy With or Without Trastuzumab: Results From North Central Cancer Treatment Group Adjuvant Trial N9831MORENO-ASPITIA, Alvaro; HILLMAN, David W; KUTTEH, Leila A et al.Cancer. 2013, Vol 119, Num 15, pp 2675-2682, issn 0008-543X, 8 p.Article

Does magnetic resonance imaging accurately predict residual disease in breast cancer?STUCKY, Chee-Chee H; MCLAUGHLIN, Sarah A; DUECK, Amylou C et al.The American journal of surgery. 2009, Vol 198, Num 4, pp 547-552, issn 0002-9610, 6 p.Article

Integrating Patient-Reported Outcomes Into Cancer Symptom Management Clinical Trials Supported by the National Cancer Institute-Sponsored Clinical Trials NetworksSLOAN, Jeff A; BERK, Lawrence; ROSCOE, Joseph et al.Journal of clinical oncology. 2007, Vol 25, Num 32, pp 5070-5077, issn 0732-183X, 8 p.Article

Radiotherapy and Adjuvant Trastuzumab in Operable Breast Cancer: Tolerability and Adverse Event Data From the NCCTG Phase III Trial N9831HALYARD, Michele Y; PISANSKY, Thomas M; KUTTEH, Leila et al.Journal of clinical oncology. 2009, Vol 27, Num 16, pp 2638-2644, issn 0732-183X, 7 p.Article

Scientific Presentation Award: The impact of magnetic resonance imaging on surgical treatment of invasive breast cancerCARPENTER, Susanne G; STUCKY, Chee-Chee; DUECK, Amylou C et al.The American journal of surgery. 2009, Vol 198, Num 4, pp 475-481, issn 0002-9610, 7 p.Article

Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity CriteriaPEREZ, Edith A; DUECK, Amylou C; JENKINS, Robert B et al.Journal of the National Cancer Institute. 2012, Vol 104, Num 2, pp 159-162, issn 0027-8874, 4 p.Article

The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): International Prospective Validation and Reliability Trial in 402 patientsSCHERBER, Robyn; DUECK, Amylou C; SAMUELSSON, Jan et al.Blood. 2011, Vol 118, Num 2, pp 401-408, issn 0006-4971, 8 p.Article

A promising approach for treatment of tumor-induced bone diseases: Utilizing bisphosphonate derivatives of nucleoside antimetabolitesREINHOLZ, Monica M; ZINNEN, Shawn P; ARENDT, Bonnie K et al.Bone (New York, NY). 2010, Vol 47, Num 1, pp 12-22, issn 8756-3282, 11 p.Article

Distinctive Pulmonary Histopathology With Increased IgG4-positive Plasma Cells in Patients With Autoimmune Pancreatitis: Report of 6 and 12 Cases With Similar HistopathologySHRESTHA, Bijayee; SEKIGUCHI, Hiroshi; DUECK, Amylou C et al.The American journal of surgical pathology. 2009, Vol 33, Num 10, pp 1450-1462, issn 0147-5185, 13 p.Article

Recommended Patient-Reported Core Set of Symptoms to Measure in Adult Cancer Treatment TrialsREEVE, Bryce B; MITCHELL, Sandra A; CHAUHAN, Cynthia et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 7, issn 0027-8874, dju129.1-dju129.8Article

Recommendations for Including Multiple Symptoms as Endpoints in Cancer Clinical Trials: A Report From the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task ForceCLEELAND, Charles S; SLOAN, Jeff A; TORIGOE, Yasuhiro et al.Cancer. 2013, Vol 119, Num 2, pp 411-420, issn 0008-543X, 10 p.Article

C-MYC Alterations and Association With Patient Outcome in Early-Stage HER2-Positive Breast Cancer From the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab TrialPEREZ, Edith A; JENKINS, Robert B; GEIGER, Xochiquetzal J et al.Journal of clinical oncology. 2011, Vol 29, Num 6, pp 651-659, issn 0732-183X, 9 p.Article

HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab TrialPEREZ, Edith A; REINHOLZ, Monica M; DUECK, Amylou C et al.Journal of clinical oncology. 2010, Vol 28, Num 28, pp 4307-4315, issn 0732-183X, 9 p.Article

Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2⁺ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831DUECK, Amylou C; REINHOLZ, Monica M; MARTINO, Silvana et al.Clinical cancer research (Print). 2013, Vol 19, Num 20, pp 5798-5807, issn 1078-0432, 10 p.Article

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancerMORENO-ASPITIA, Alvaro; DUECK, Amylou C; RODEHEFFER, Richard et al.Breast cancer research and treatment. 2013, Vol 138, Num 2, pp 427-435, issn 0167-6806, 9 p.Article

Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNsEMANUEL, Robyn M; DUECK, Amylou C; FUENTES, Ana Kerguelen et al.Journal of clinical oncology. 2012, Vol 30, Num 33, pp 4098-4103, issn 0732-183X, 6 p.Article

Pretransplant Risk Score for New-Onset Diabetes After Kidney TransplantationCHAKKERA, Harini A; JENNIFER WEIL, E; KATARIYA, Nitin et al.Diabetes care. 2011, Vol 34, Num 10, pp 2141-2145, issn 0149-5992, 5 p.Article

Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437REINHOLZ, Monica M; KITZMANN, Kathleen A; ALLRED, Jake B et al.Clinical cancer research (Print). 2011, Vol 17, Num 22, pp 7183-7193, issn 1078-0432, 11 p.Article